How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
Portfolio Pulse from Avi Kapoor
Johnson & Johnson (NYSE:JNJ) is set to release its Q2 earnings on July 17, with analysts expecting an EPS of $2.70 and revenue of $22.29 billion. The company offers a 3.32% annual dividend yield. Emergent BioSolutions (NYSE:EBS) has settled a dispute with J&J's Janssen Pharmaceuticals regarding COVID-19 vaccine manufacturing.

July 16, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Emergent BioSolutions has settled a dispute with Johnson & Johnson's Janssen Pharmaceuticals regarding the manufacturing of J&J's investigational COVID-19 vaccine.
The settlement of the dispute with J&J's Janssen Pharmaceuticals removes a legal overhang for Emergent BioSolutions, which could positively impact its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Johnson & Johnson is expected to report Q2 earnings with an EPS of $2.70 and revenue of $22.29 billion. The company offers a 3.32% annual dividend yield. Shares fell 0.4% to $149.24 recently.
The upcoming earnings report and the company's strong dividend yield are likely to attract investor interest, potentially driving the stock price up in the short term. The recent slight decline in share price may present a buying opportunity.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100